Nicholas N. Vahanian

2010

In 2010, Nicholas N. Vahanian earned a total compensation of $1.2M as President and Chief Medical Officer at NewLink Genetics, a 30% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$139,313
Option Awards$640,463
Salary$312,322
Other$78,571
Total$1,170,669

Vahanian received $640.5K in option awards, accounting for 55% of the total pay in 2010.

Vahanian also received $139.3K in non-equity incentive plan, $312.3K in salary and $78.6K in other compensation.

Rankings

In 2010, Nicholas N. Vahanian's compensation ranked 4,752nd out of 10,439 executives tracked by ExecPay. In other words, Vahanian earned more than 54.5% of executives.

ClassificationRankingPercentile
All
4,752
out of 10,439
55th
Division
Manufacturing
1,700
out of 3,838
56th
Major group
Chemicals And Allied Products
346
out of 921
62nd
Industry group
Drugs
197
out of 680
71st
Industry
Pharmaceutical Preparations
152
out of 481
68th
Source: SEC filing on September 21, 2012.

Vahanian's colleagues

We found four more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2010.

2010

Charles Link

NewLink Genetics

Chairman

2010

W Ramsey

NewLink Genetics

Quality Assurance Officer

2010

Gordon Link

NewLink Genetics

Chief Financial Officer

2010

Kenneth Lynn

NewLink Genetics

Executive Vice President of Business Development

News

In-depth

You may also like